MAP2K1 and lung adenocarcinoma: A complementary study demonstrated that MAPK signalling regulated epidermal growth factor- and interferon-gamma-induced PD-L1 expression in lung adenocarcinoma cells and that inhibition of MEK1/2 attenuated PD-L1 upregulation29.